{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T07:27:01Z","timestamp":1761290821841},"reference-count":69,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2001,8,1]],"date-time":"2001-08-01T00:00:00Z","timestamp":996624000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice &amp; Research Clinical Gastroenterology"],"published-print":{"date-parts":[[2001,8]]},"DOI":"10.1053\/bega.2001.0206","type":"journal-article","created":{"date-parts":[[2002,9,19]],"date-time":"2002-09-19T13:54:50Z","timestamp":1032443690000},"page":"577-589","source":"Crossref","is-referenced-by-count":16,"title":["Aetiopathogenesis of primary sclerosing cholangitis"],"prefix":"10.1053","volume":"15","author":[{"given":"Sue","family":"Cullen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roger","family":"Chapman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/bega.2001.0206_RF1","doi-asserted-by":"crossref","first-page":"655","DOI":"10.3109\/00365528709011139","article-title":"Primary sclerosing cholangitis: a long term follow-up study","volume":"22","author":"Aadland","year":"1987","journal-title":"Scandinavian Journal of Gastroenterology"},{"key":"10.1053\/bega.2001.0206_RF2","first-page":"1585","article-title":"Familial occurrence of liver disease and inflammatory bowel disease in primary sclerosing cholangitis","volume":"92","author":"Quigley","year":"1987","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2001.0206_RF3","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0168-8278(94)80240-8","article-title":"Epidemiology of primary sclerosing cholangitis in Spain","volume":"21","author":"Escorsell","year":"1994","journal-title":"Journal of Hepatology"},{"key":"10.1053\/bega.2001.0206_RF4","first-page":"685","article-title":"Primary Italian multicentre study","volume":"8","author":"Okolicsanyi","year":"1996","journal-title":"European Journal of Gastroenterology and Hepatology"},{"key":"10.1053\/bega.2001.0206_RF5","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1007\/s005340050129","article-title":"Recent status of primary sclerosing cholangitis in Japan","volume":"6","author":"Takikawa","year":"1999","journal-title":"Journal of Hepato-Biliary-Pancreatic Surgery"},{"key":"10.1053\/bega.2001.0206_RF6","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1055\/s-2008-1040541","article-title":"Hepatobiliary complications of inflammatory bowel disease","volume":"8","author":"Schrumpf","year":"1988","journal-title":"Seminars in Liver Disease"},{"key":"10.1053\/bega.2001.0206_RF7","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.1111\/j.1572-0241.2000.03292.x","article-title":"Increased frequency of autoimmune diseases in patients with primary sclerosing cholangitis","volume":"95","author":"Saarinen","year":"2000","journal-title":"American Journal of Gastroenterology"},{"key":"10.1053\/bega.2001.0206_RF8","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1016\/0016-5085(91)70028-V","article-title":"Neutrophil cytoplasmic antibodies: a link between primary sclerosing cholangitis and ulcerative colitis","volume":"100","author":"Duerr","year":"1991","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2001.0206_RF9","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1136\/gut.33.10.1370","article-title":"Prevalence of antineutrophil antibody in primary sclerosing cholangitis and ulcerative colitis using an alkaline phosphatase technique","volume":"33","author":"Lo","year":"1992","journal-title":"Gut"},{"key":"10.1053\/bega.2001.0206_RF10","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/S0168-8278(05)80604-X","article-title":"A two year follow-up study of antineutrophil antibody in primary sclerosing cholangitis","volume":"21","author":"Lo","year":"1994","journal-title":"Journal of Hepatology"},{"key":"10.1053\/bega.2001.0206_RF11","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1053\/gast.2000.9366","article-title":"\u2018Atypical p-ANCA\u2019 in IBD and hepatobiliary disorders react with a 50 kilodalton nuclear envelope protein of neutrophils and myeloid cell lines","volume":"119","author":"Terjung","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2001.0206_RF12","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1136\/gut.38.3.384","article-title":"Importance of antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis and ulcerative colitis: prevalence, titre, and IgG subclass","volume":"38","author":"Bansi","year":"1996","journal-title":"Gut"},{"key":"10.1053\/bega.2001.0206_RF13","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/978-1-4757-9068-9_39","article-title":"Prevalence and clinical significance of anti-lactoferrin autoantibodies in inflammatory bowel diseases and primary sclerosing cholangitis","volume":"443","author":"Roozendaal","year":"1998","journal-title":"Advances in Experimental Medicine and Biology"},{"key":"10.1053\/bega.2001.0206_RF14","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0002-9343(98)00294-0","article-title":"Anti-neutrophil cytoplasmic antibodies in primary sclerosing cholangitis: defined specificites may be associated with distinct clinical features","volume":"105","author":"Roozendaal","year":"1998","journal-title":"American Journal of Medicine"},{"key":"10.1053\/bega.2001.0206_RF15","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1136\/gut.27.1.86","article-title":"Serum autoantibodies, ulcerative colitis and primary sclerosing cholangitis","volume":"27","author":"Chapman","year":"1986","journal-title":"Gut"},{"key":"10.1053\/bega.2001.0206_RF16","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/0016-5085(90)90839-S","article-title":"A shared and unique epitope(s) on human colon, skin, and biliary epithelium detected by a monoclonal antibody","volume":"98","author":"Das","year":"1990","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2001.0206_RF17","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0016-5085(94)95271-X","article-title":"Autoantibodies in sclerosing cholangitis against a shared peptide in biliary and colon epithelium","volume":"106","author":"Mandal","year":"1994","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2001.0206_RF18","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0168-8278(00)80061-6","article-title":"Serum autoantibodies in patients with primary sclerosing cholangitis","volume":"32","author":"Angulo","year":"2000","journal-title":"Journal of Hepatology"},{"key":"10.1053\/bega.2001.0206_RF19","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/hep.1840030203","article-title":"Elevated circulating immune complexes in primary sclerosing cholangitis","volume":"3","author":"Bodenheimer","year":"1983","journal-title":"Hepatology"},{"key":"10.1053\/bega.2001.0206_RF20","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1016\/0016-5085(89)90386-7","article-title":"Activation of the complement system in primary sclerosing cholangitis","volume":"97","author":"Senaldi","year":"1989","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2001.0206_RF21","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1136\/gut.34.7.977","article-title":"Inappropriate expression of blood group antigens on biliary and colonic epithelia in primary sclerosing cholangitis","volume":"34","author":"Bloom","year":"1993","journal-title":"Gut"},{"key":"10.1053\/bega.2001.0206_RF22","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0168-8278(97)80417-5","article-title":"Preferential V 3 usage by hepatic T lymphocytes in patients with primary sclerosing cholangitis","volume":"26","author":"Broom\u00e9","year":"1997","journal-title":"Journal of Hepatology"},{"key":"10.1053\/bega.2001.0206_RF23","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.4049\/jimmunol.158.4.1941","article-title":"Analysis of human common bile duct-associated T cells: evidence of oligoclonality, T cell clonal persistence, and epithelial cell recognition","volume":"158","author":"Probert","year":"1997","journal-title":"Journal of Immunology"},{"key":"10.1053\/bega.2001.0206_RF24","doi-asserted-by":"crossref","first-page":"G245","DOI":"10.1152\/ajpgi.2000.279.2.G245","article-title":"Fibrogenesis. II. Metalloproteinases and their inhibitors in liver fibrosis","volume":"279","author":"Arthur","year":"2000","journal-title":"American Journal of Physiology. Gastrointestinal and Liver Physiology"},{"key":"10.1053\/bega.2001.0206_RF25","doi-asserted-by":"crossref","first-page":"G7","DOI":"10.1152\/ajpgi.2000.279.1.G7","article-title":"Fibrogenesis. I. New Insights into hepatic stellate cell activation: the simple becomes complex","volume":"279","author":"Eng","year":"2000","journal-title":"American Journal of Physiology. Gastrointestinal and Liver Physiology"},{"key":"10.1053\/bega.2001.0206_RF26","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3109\/00365528209182038","article-title":"HLA antigens and immunregulatory T cells in ulcerative colitis associated with hepatobiliary disease","volume":"17","author":"Schrumpf","year":"1982","journal-title":"Scandinavian Journal of Gastroenterology"},{"key":"10.1053\/bega.2001.0206_RF27","first-page":"503","article-title":"Ulcerative colitis and persistent liver dysfunstion","volume":"52","author":"Shepherd","year":"1983","journal-title":"Quarterly Journal of Medicine"},{"key":"10.1053\/bega.2001.0206_RF28","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1136\/gut.24.1.38","article-title":"Association of primary sclerosing cholangitis with HLA-B8","volume":"24","author":"Chapman","year":"1983","journal-title":"Gut"},{"key":"10.1053\/bega.2001.0206_RF29","unstructured":"Donaldson, P, Immunogenetics or primary sclerosing cholangitis"},{"key":"10.1053\/bega.2001.0206_RF30","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3109\/00365529409103625","article-title":"Etiology and pathogenesis in primary sclerosing cholangitis","volume":"29","author":"Boberg","year":"1994","journal-title":"Scandinavian Journal of Gastroenterology"},{"key":"10.1053\/bega.2001.0206_RF31","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1056\/NEJM199006283222603","article-title":"Association of primary sclerosing cholangitis with HLA DRw52a","volume":"322","author":"Prochazka","year":"1990","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/bega.2001.0206_RF32","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/hep.1840160217","article-title":"Amino acid substitutions at position 38 of the DR polypeptide confer susceptibility to and protection from primary sclerosing cholangitis","volume":"16","author":"Farrant","year":"1992","journal-title":"Hepatology"},{"key":"10.1053\/bega.2001.0206_RF33","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/0016-5085(95)90463-8","article-title":"HLA-DR and HLA-DQ are not markers for rapid disease progression in primary sclerosing cholangitis","volume":"108","author":"Olerup","year":"1995","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2001.0206_RF34","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1034\/j.1399-0039.1999.530502.x","article-title":"HLA class II haplotypes in primary sclerosing cholangitis from five European populations","volume":"53","author":"Spurkland","year":"1999","journal-title":"Tissue Antigens"},{"key":"10.1053\/bega.2001.0206_RF35","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/S0016-5085(94)95085-7","article-title":"HLA DR4 is a marker for rapid disease progression in primary sclerosing cholangitis","volume":"106","author":"Mehal","year":"1994","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2001.0206_RF36","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0168-8278(99)80068-3","article-title":"Association of tumour necrosis factor polymorphism with primary sclerosing cholangitis","volume":"30","author":"Bernal","year":"1999","journal-title":"Journal of Hepatology"},{"key":"10.1053\/bega.2001.0206_RF37","doi-asserted-by":"crossref","DOI":"10.1136\/gut.49.2.288","article-title":"Association of the TNF\u2212308 but not the interleukin-10\u2212592 promoter polymorphism with genetic susceptibility to primary sclerosing cholangitis","author":"Mitchell","year":"2001","journal-title":"Gut"},{"key":"10.1053\/bega.2001.0206_RF38","first-page":"A1361","article-title":"Strong association between PSC HLA-encoded gene MICA*008: is this the primary susceptibility allele?","volume":"30","author":"Norris","year":"1999","journal-title":"Abstract Hepatology"},{"key":"10.1053\/bega.2001.0206_RF39","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/S0168-8278(00)80091-4","article-title":"The interleukin-1 and interleukin-10 gene polymorphisms in primary sclerosing cholangitis: no association with disease susceptibility\/resistance","volume":"32","author":"Donaldson","year":"2000","journal-title":"Journal of Hepatology"},{"key":"10.1053\/bega.2001.0206_RF40","doi-asserted-by":"crossref","DOI":"10.1053\/gast.2001.25527","article-title":"A functional polymorphism of the stromelysin gene (MMP-3) determines susceptibility and disease progression in primary sclersoing cholangitis","author":"Satsangi","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2001.0206_RF41","doi-asserted-by":"crossref","first-page":"126","DOI":"10.3109\/00365529309096058","article-title":"Lack of concomitant expression of ICAM-1 and HLA-DR on bile duct cells from patients with primary sclerosing cholangitis and primary biliary cirrhosis","volume":"28","author":"Broom\u00e9","year":"1993","journal-title":"Scandinavian Journal of Gastroenterology"},{"key":"10.1053\/bega.2001.0206_RF42","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/hep.1840160220","article-title":"Administration of interleukin-2 induces major histocompatability complex class II expression on the biliary epithelial cells, possibly through endogenous interferon-gamma production","volume":"16","author":"Himeno","year":"1992","journal-title":"Hepatology"},{"key":"10.1053\/bega.2001.0206_RF43","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1136\/gut.34.9.1245","article-title":"Intercellular adhesion molecule-1 and MHC antigens on human intrahepatic bile duct cells: effect of pro-inflammatory cytokines","volume":"34","author":"Ayres","year":"1993","journal-title":"Gut"},{"key":"10.1053\/bega.2001.0206_RF44","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/hep.1840160220","article-title":"Expression and cytokine regulation of immune recognition elements by normal human biliary epithelial cells, possibly through endogenous interferon-gamma production","volume":"16","author":"Cruikshank","year":"1992","journal-title":"Hepatology"},{"key":"10.1053\/bega.2001.0206_RF45","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1002\/hep.510240317","article-title":"Immunogenicity of biliary epithelium: investigation of antigen presentation to CD4+ T cells","volume":"24","author":"Leon","year":"1996","journal-title":"Hepatology"},{"key":"10.1053\/bega.2001.0206_RF46","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/S0168-8278(99)80315-8","article-title":"Inhibition of T cell activation by normal human biliary epithelial cells","volume":"31","author":"Cruikshank","year":"1999","journal-title":"Journal of Hepatology"},{"key":"10.1053\/bega.2001.0206_RF47","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/(SICI)1096-9896(1998100)186:2<126::AID-PATH167>3.0.CO;2-1","article-title":"Expression of co-stimulatory factor B7-2 on the intrahepatic bile ducts in primary biliary cirrhosis and primary sclerosing cholangitis: an immunohistochemical study","volume":"186","author":"Tsuneyama","year":"1998","journal-title":"Journal of Pathology"},{"key":"10.1053\/bega.2001.0206_RF48","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0140-6736(59)92049-5","article-title":"The liver in ulcerative colitis. The significance of raised serum alkaline phosphatase levels","volume":"2","author":"Boden","year":"1959","journal-title":"Lancet"},{"key":"10.1053\/bega.2001.0206_RF49","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1136\/pgmj.37.427.245","article-title":"A study of liver disorder in ulcerative colitis","volume":"37","author":"Brooke","year":"1961","journal-title":"Postgraduate Medical Journal"},{"key":"10.1053\/bega.2001.0206_RF50","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/S0168-8278(98)80316-4","article-title":"Bile duct bacterial isolates in PSC: a study of explanted livers","volume":"28","author":"Olsson","year":"1998","journal-title":"Journal of Hepatology"},{"key":"10.1053\/bega.2001.0206_RF51","unstructured":"Vierling, J, Aetiopathogenesis of primary sclerosing cholangitis, Manns, PChapman, R, WStieihl, AWiesner, R, Primary Sclerosing Cholangitis, London, Kluwer Academic Publishers, 1998, 37, 45"},{"key":"10.1053\/bega.2001.0206_RF52","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1055\/s-2008-1040416","article-title":"Pathogenesis of sclerosing cholangitis: the role of nonimmune factors","volume":"11","author":"Sherlock","year":"1991","journal-title":"Seminars Liver Disease"},{"key":"10.1053\/bega.2001.0206_RF53","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/0002-9343(89)90381-1","article-title":"Acquired immunodeficiency syndrome cholangiopathy: spectrum of disease","volume":"86","author":"Cello","year":"1989","journal-title":"American Journal of Medicine"},{"key":"10.1053\/bega.2001.0206_RF54","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1016\/0016-5085(92)91743-N","article-title":"Enterocytozoon bieneusi infection in acquired immunodeficiency syndrome-related sclerosing cholangitis","volume":"102","author":"Pol","year":"1992","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2001.0206_RF55","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1136\/bmj.284.6317.706","article-title":"Non-smoking: a feature of ulcerative colitis","volume":"284","author":"Harries","year":"1982","journal-title":"British Medical Journal"},{"key":"10.1053\/bega.2001.0206_RF56","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1053\/gast.1996.v110.pm8613055","article-title":"Primary sclerosing cholangitis is associated with non-smoking \u2013 a case-control study","volume":"110","author":"Loftus","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2001.0206_RF57","first-page":"446A","article-title":"Cigarette smoking, appendectomy and tonsillectomy as risk factors for thedevelopment of primary sclerosing cholangitis: a case control study","volume":"28","author":"Mitchell","year":"1998","journal-title":"Hepatology"},{"key":"10.1053\/bega.2001.0206_RF58","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/hep.510270201","article-title":"Risk factors and clinical presentation of hepatobiliary carcinoma in patients with primary sclerosing cholangitis: a case-control study","volume":"27","author":"Bergquist","year":"1998","journal-title":"Hepatology"},{"key":"10.1053\/bega.2001.0206_RF59","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/hep.1840090209","article-title":"Floxuridine-induced sclerosing cholangitis: an ischaemic cholangiopathy?","volume":"9","author":"Ludwig","year":"1989","journal-title":"Hepatology"},{"key":"10.1053\/bega.2001.0206_RF60","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1136\/gut.46.4.443","article-title":"Is liver fibrosis reversible?","volume":"46","author":"Benyon","year":"2000","journal-title":"Gut"},{"key":"10.1053\/bega.2001.0206_RF61","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1002\/hep.1840150603","article-title":"Role of extracellular matrix in regulating fenestrations of endothelial cells isolated from normal rat liver","volume":"15","author":"McGuire","year":"1992","journal-title":"Hepatology"},{"key":"10.1053\/bega.2001.0206_RF62","first-page":"187","article-title":"Transcriptional regulation of the albumin gene in cultured rat hepatocytes. Role of basement membranematrix","volume":"7","author":"Bissell","year":"1990","journal-title":"Molecular Biology and Medicine"},{"key":"10.1053\/bega.2001.0206_RF63","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1172\/JCI112887","article-title":"Support of cultured hepatocytes by a laminin-rich gel","volume":"79","author":"Bissell","year":"1987","journal-title":"Journal of Clinical Investigation"},{"key":"10.1053\/bega.2001.0206_RF64","doi-asserted-by":"crossref","first-page":"10756","DOI":"10.1016\/S0021-9258(18)81686-6","article-title":"Maintenance of differentiated phenotype of cultured rat hepatic lipocytes by basement membrane matrix","volume":"264","author":"Friedman","year":"1989","journal-title":"Journal of Biological Chemistry"},{"key":"10.1053\/bega.2001.0206_RF65","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0049-3848(98)00122-4","article-title":"Development and disease in proteinase-deficient mice; role of the plasminogen, matrix metalloproteinase and coagulation system","volume":"91","author":"Carmeliet","year":"1998","journal-title":"Thrombosis Research"},{"key":"10.1053\/bega.2001.0206_RF66","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1023\/A:1026601904609","article-title":"Regression of hepatic fibrosis in hepatitis C with longterm interferon treatment","volume":"43","author":"Dufour","year":"1998","journal-title":"Digestive Diseases and Sciences"},{"key":"10.1053\/bega.2001.0206_RF67","doi-asserted-by":"crossref","first-page":"981","DOI":"10.7326\/0003-4819-127-11-199712010-00006","article-title":"Reversibility of hepatic fibrosis in autoimmune hepatitis","volume":"127","author":"Du Four","year":"1997","journal-title":"Annals of Internal Medicine"},{"key":"10.1053\/bega.2001.0206_RF68","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1056\/NEJM198511143132004","article-title":"Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis","volume":"313","author":"Niederau","year":"1985","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/bega.2001.0206_RF69","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/S0016-5085(99)70135-6","article-title":"Modeling the impact of interferon alfa treatment on liver fibrosis progression in chronic hepatitis C: a dynamic view. The Multiviric Group","volume":"116","author":"Sobesky","year":"1999","journal-title":"Gastroenterology"}],"container-title":["Best Practice &amp; Research Clinical Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521691801902069?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521691801902069?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,22]],"date-time":"2023-04-22T04:43:53Z","timestamp":1682138633000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521691801902069"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,8]]},"references-count":69,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2001,8]]}},"alternative-id":["S1521691801902069"],"URL":"https:\/\/doi.org\/10.1053\/bega.2001.0206","relation":{},"ISSN":["1521-6918"],"issn-type":[{"value":"1521-6918","type":"print"}],"subject":[],"published":{"date-parts":[[2001,8]]}}}